Epitome
Search documents
nDatalyze Corp. Completes Multi-Team Data Collection and Calibration for Epitome Sports Analytics Platform
Thenewswire· 2025-12-15 17:05
Calgary, AB – TheNewswire - December 15, 2025 – nDatalyze Corp. (CSE: NDAT) (the “Company”) today announced the completion of a key development milestone for Epitome, its proprietary AI-driven sports performance analytics platform, with data collection, testing, and calibration finalized across three organized hockey teams. The completed dataset includes athletes from two Western Hockey League (WHL) teams and one Ontario University Athletics (OUA) program, providing a multi-level development sample. Manage ...
nDatalyze Corp. announces initiation of "Epitome", a Predictive Sports Performance Project leveraging AI to address a Multi-Billion Dollar Sports Analytics Market
Thenewswire· 2025-09-04 17:15
Core Insights - nDatalyze Corp. has launched "Epitome," a sports performance analytics project utilizing advanced machine learning to enhance professional hockey performance, tapping into a global sports analytics market projected to exceed USD $22 billion by 2030 [1][2] Value Proposition - Epitome employs proprietary biometric modeling technology to predict athletic performance, addressing a significant challenge in professional sports that could reduce risks and enhance returns for NHL franchises [2] - The project positions nDatalyze at the intersection of AI, genomics, and sports analytics, creating substantial commercial potential [2] Industry Demand & Economic Rationale - The inefficiencies in player drafting and development are highlighted, with only 19% of NHL draftees playing over 200 games, leading to significant financial losses [4] - The project aims to de-risk multimillion-dollar decisions in player selection by adapting clinically studied algorithms for sports applications [4] Progress & Strategic Positioning - Epitome reflects nDatalyze's commitment to commercializing its AI-driven biometric technology across high-value sectors, targeting a multi-billion dollar market with a clinically grounded solution [5] - The initiative is expected to deliver meaningful shareholder value and establish the company as a leader in predictive sports performance analytics [5] Signature Modeling - Epitome creates a unique "Signature" for each player by integrating biometric data, performance statistics, genetic predispositions, and algorithmic scores [6] - The system benchmarks individual Signatures against those of proven high-performance players to establish predictive metrics [6] - Applications include assessing future performance prospects, optimizing roster configurations, and developing personalized coaching protocols [6] Project Support and Financing - nDatalyze has secured commitments from three advisors, including former NHL coaches, to define the digital "high-performance player" [7] - The project is fully financed through existing cash, ensuring no dilution to shareholders at this stage [7] - Epitome is included in the proposed spinout related to the previously announced RTO, benefiting pre-RTO shareholders regardless of the RTO's closure [7]